Mission magazine banner

HSC/UTSA collaborate with Merck to develop vaccine

September 2009

The Health Science Center and the University of Texas at San Antonio (UTSA) announced an exclusive license and sponsored research agreement with Merck & Co. Inc. to develop a vaccine for chlamydia, targeting the common sexually transmitted bacterium Chlamydia trachomatis. "The Health Science Center strives not only to make discoveries that improve the quality of life but also to make sure these breakthroughs are rapidly disseminated through the commercialization process so they can help as many people as possible," said Brian Herman, Ph.D., vice president for research at the Health Science Center. "We welcome this opportunity to further advance our already successful collaboration with UTSA."


More stories:

Read current stories



Previous Issues

Current Issue (PDF)


Email us

HSC News

Make a Gift

University Home

UT Health Science Center
7703 Floyd Curl Dr.
San Antonio, Texas

© 2002 - 2015 UTHSCSA
Office of Communications
All rights reserved.

Links provided from UTHSCSA pages to other websites do not constitute or imply an endorsement of those sites, their content, or products and services associated with those sites.

Updated 12/11/14